Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.

Identifieur interne : 000012 ( PubMed/Corpus ); précédent : 000011; suivant : 000013

Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.

Auteurs : Guo Luo ; Aditya Ambati ; Ling Lin ; Mélodie Bonvalet ; Markku Partinen ; Xuhuai Ji ; Holden Terry Maecker ; Emmanuel Jean-Marie Mignot

Source :

RBID : pubmed:30541895

English descriptors

Abstract

Type 1 narcolepsy (T1N) is caused by hypocretin/orexin (HCRT) neuronal loss. Association with the HLA DQB1*06:02/DQA1*01:02 (98% vs. 25%) heterodimer (DQ0602), T cell receptors (TCR) and other immune loci suggest autoimmunity but autoantigens are unknown. Onset is seasonal and associated with influenza A, notably pandemic 2009 H1N1 (pH1N1) infection and vaccination (Pandemrix). Peptides derived from HCRT and influenza A, including pH1N1, were screened for DQ0602 binding and presence of cognate DQ0602 tetramer-peptide-specific CD4+ T cells tested in 35 T1N cases and 22 DQ0602 controls. Higher reactivity to influenza pHA273-287 (pH1N1 specific), PR8 (H1N1 pre-2009 and H2N2)-specific NP17-31 and C-amidated but not native version of HCRT54-66 and HCRT86-97 (HCRTNH2) were observed in T1N. Single-cell TCR sequencing revealed sharing of CDR3β TRBV4-2-CASSQETQGRNYGYTF in HCRTNH2 and pHA273-287-tetramers, suggesting molecular mimicry. This public CDR3β uses TRBV4-2, a segment modulated by T1N-associated SNP rs1008599, suggesting causality. TCR-α/β CDR3 motifs of HCRT54-66-NH2 and HCRT86-97-NH2 tetramers were extensively shared: notably public CDR3α, TRAV2-CAVETDSWGKLQF-TRAJ24, that uses TRAJ24, a chain modulated by T1N-associated SNPs rs1154155 and rs1483979. TCR-α/β CDR3 sequences found in pHA273-287, NP17-31, and HCRTNH2 tetramer-positive CD4+ cells were also retrieved in single INF-γ-secreting CD4+ sorted cells stimulated with Pandemrix, independently confirming these results. Our results provide evidence for autoimmunity and molecular mimicry with flu antigens modulated by genetic components in the pathophysiology of T1N.

DOI: 10.1073/pnas.1818150116
PubMed: 30541895

Links to Exploration step

pubmed:30541895

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.</title>
<author>
<name sortKey="Luo, Guo" sort="Luo, Guo" uniqKey="Luo G" first="Guo" last="Luo">Guo Luo</name>
<affiliation>
<nlm:affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ambati, Aditya" sort="Ambati, Aditya" uniqKey="Ambati A" first="Aditya" last="Ambati">Aditya Ambati</name>
<affiliation>
<nlm:affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lin, Ling" sort="Lin, Ling" uniqKey="Lin L" first="Ling" last="Lin">Ling Lin</name>
<affiliation>
<nlm:affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bonvalet, Melodie" sort="Bonvalet, Melodie" uniqKey="Bonvalet M" first="Mélodie" last="Bonvalet">Mélodie Bonvalet</name>
<affiliation>
<nlm:affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Partinen, Markku" sort="Partinen, Markku" uniqKey="Partinen M" first="Markku" last="Partinen">Markku Partinen</name>
<affiliation>
<nlm:affiliation>Helsinki Sleep Clinic, Vitalmed Research Centre, 00380 Helsinki, Finland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ji, Xuhuai" sort="Ji, Xuhuai" uniqKey="Ji X" first="Xuhuai" last="Ji">Xuhuai Ji</name>
<affiliation>
<nlm:affiliation>Immune Monitoring Center, Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Palo Alto, CA 94305.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Maecker, Holden Terry" sort="Maecker, Holden Terry" uniqKey="Maecker H" first="Holden Terry" last="Maecker">Holden Terry Maecker</name>
<affiliation>
<nlm:affiliation>Immune Monitoring Center, Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Palo Alto, CA 94305.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mignot, Emmanuel Jean Marie" sort="Mignot, Emmanuel Jean Marie" uniqKey="Mignot E" first="Emmanuel Jean-Marie" last="Mignot">Emmanuel Jean-Marie Mignot</name>
<affiliation>
<nlm:affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304; mignot@stanford.edu.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:30541895</idno>
<idno type="pmid">30541895</idno>
<idno type="doi">10.1073/pnas.1818150116</idno>
<idno type="wicri:Area/PubMed/Corpus">000012</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000012</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.</title>
<author>
<name sortKey="Luo, Guo" sort="Luo, Guo" uniqKey="Luo G" first="Guo" last="Luo">Guo Luo</name>
<affiliation>
<nlm:affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ambati, Aditya" sort="Ambati, Aditya" uniqKey="Ambati A" first="Aditya" last="Ambati">Aditya Ambati</name>
<affiliation>
<nlm:affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lin, Ling" sort="Lin, Ling" uniqKey="Lin L" first="Ling" last="Lin">Ling Lin</name>
<affiliation>
<nlm:affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bonvalet, Melodie" sort="Bonvalet, Melodie" uniqKey="Bonvalet M" first="Mélodie" last="Bonvalet">Mélodie Bonvalet</name>
<affiliation>
<nlm:affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Partinen, Markku" sort="Partinen, Markku" uniqKey="Partinen M" first="Markku" last="Partinen">Markku Partinen</name>
<affiliation>
<nlm:affiliation>Helsinki Sleep Clinic, Vitalmed Research Centre, 00380 Helsinki, Finland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ji, Xuhuai" sort="Ji, Xuhuai" uniqKey="Ji X" first="Xuhuai" last="Ji">Xuhuai Ji</name>
<affiliation>
<nlm:affiliation>Immune Monitoring Center, Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Palo Alto, CA 94305.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Maecker, Holden Terry" sort="Maecker, Holden Terry" uniqKey="Maecker H" first="Holden Terry" last="Maecker">Holden Terry Maecker</name>
<affiliation>
<nlm:affiliation>Immune Monitoring Center, Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Palo Alto, CA 94305.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mignot, Emmanuel Jean Marie" sort="Mignot, Emmanuel Jean Marie" uniqKey="Mignot E" first="Emmanuel Jean-Marie" last="Mignot">Emmanuel Jean-Marie Mignot</name>
<affiliation>
<nlm:affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304; mignot@stanford.edu.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Proceedings of the National Academy of Sciences of the United States of America</title>
<idno type="eISSN">1091-6490</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Autoantigens (metabolism)</term>
<term>Autoimmunity (immunology)</term>
<term>CD4-Positive T-Lymphocytes (immunology)</term>
<term>Child</term>
<term>Epitopes (immunology)</term>
<term>Female</term>
<term>HLA-DQ beta-Chains</term>
<term>Hemagglutinins</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza A virus (pathogenicity)</term>
<term>Influenza, Human (immunology)</term>
<term>Intracellular Signaling Peptides and Proteins (genetics)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Molecular Mimicry (immunology)</term>
<term>Narcolepsy (immunology)</term>
<term>Orexins (genetics)</term>
<term>Orexins (immunology)</term>
<term>Orexins (metabolism)</term>
<term>Peptides (genetics)</term>
<term>Receptors, Antigen, T-Cell (genetics)</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Intracellular Signaling Peptides and Proteins</term>
<term>Orexins</term>
<term>Peptides</term>
<term>Receptors, Antigen, T-Cell</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Epitopes</term>
<term>Orexins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Autoantigens</term>
<term>Orexins</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Autoimmunity</term>
<term>CD4-Positive T-Lymphocytes</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A virus</term>
<term>Influenza, Human</term>
<term>Molecular Mimicry</term>
<term>Narcolepsy</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Female</term>
<term>HLA-DQ beta-Chains</term>
<term>Hemagglutinins</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Vaccination</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Type 1 narcolepsy (T1N) is caused by hypocretin/orexin (HCRT) neuronal loss. Association with the HLA DQB1*06:02/DQA1*01:02 (98% vs. 25%) heterodimer (DQ0602), T cell receptors (TCR) and other immune loci suggest autoimmunity but autoantigens are unknown. Onset is seasonal and associated with influenza A, notably pandemic 2009 H1N1 (pH1N1) infection and vaccination (Pandemrix). Peptides derived from HCRT and influenza A, including pH1N1, were screened for DQ0602 binding and presence of cognate DQ0602 tetramer-peptide-specific CD4
<sup>+</sup>
T cells tested in 35 T1N cases and 22 DQ0602 controls. Higher reactivity to influenza pHA
<sub>273-287</sub>
(pH1N1 specific), PR8 (H1N1 pre-2009 and H2N2)-specific NP
<sub>17-31</sub>
and C-amidated but not native version of HCRT
<sub>54-66</sub>
and HCRT
<sub>86-97</sub>
(HCRT
<sub>NH2</sub>
) were observed in T1N. Single-cell TCR sequencing revealed sharing of CDR3β TRBV4-2-CASSQETQGRNYGYTF in HCRT
<sub>NH2</sub>
and pHA
<sub>273-287</sub>
-tetramers, suggesting molecular mimicry. This public CDR3β uses TRBV4-2, a segment modulated by T1N-associated SNP rs1008599, suggesting causality. TCR-α/β CDR3 motifs of HCRT
<sub>54-66-NH2</sub>
and HCRT
<sub>86-97-NH2</sub>
tetramers were extensively shared: notably public CDR3α, TRAV2-CAVETDSWGKLQF-TRAJ24, that uses TRAJ24, a chain modulated by T1N-associated SNPs rs1154155 and rs1483979. TCR-α/β CDR3 sequences found in pHA
<sub>273-287</sub>
, NP
<sub>17-31</sub>
, and HCRT
<sub>NH2</sub>
tetramer-positive CD4
<sup>+</sup>
cells were also retrieved in single INF-γ-secreting CD4
<sup>+</sup>
sorted cells stimulated with Pandemrix, independently confirming these results. Our results provide evidence for autoimmunity and molecular mimicry with flu antigens modulated by genetic components in the pathophysiology of T1N.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">30541895</PMID>
<DateCompleted>
<Year>2019</Year>
<Month>03</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1091-6490</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>115</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2018</Year>
<Month>12</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
<ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
</Journal>
<ArticleTitle>Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.</ArticleTitle>
<Pagination>
<MedlinePgn>E12323-E12332</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1818150116</ELocationID>
<Abstract>
<AbstractText>Type 1 narcolepsy (T1N) is caused by hypocretin/orexin (HCRT) neuronal loss. Association with the HLA DQB1*06:02/DQA1*01:02 (98% vs. 25%) heterodimer (DQ0602), T cell receptors (TCR) and other immune loci suggest autoimmunity but autoantigens are unknown. Onset is seasonal and associated with influenza A, notably pandemic 2009 H1N1 (pH1N1) infection and vaccination (Pandemrix). Peptides derived from HCRT and influenza A, including pH1N1, were screened for DQ0602 binding and presence of cognate DQ0602 tetramer-peptide-specific CD4
<sup>+</sup>
T cells tested in 35 T1N cases and 22 DQ0602 controls. Higher reactivity to influenza pHA
<sub>273-287</sub>
(pH1N1 specific), PR8 (H1N1 pre-2009 and H2N2)-specific NP
<sub>17-31</sub>
and C-amidated but not native version of HCRT
<sub>54-66</sub>
and HCRT
<sub>86-97</sub>
(HCRT
<sub>NH2</sub>
) were observed in T1N. Single-cell TCR sequencing revealed sharing of CDR3β TRBV4-2-CASSQETQGRNYGYTF in HCRT
<sub>NH2</sub>
and pHA
<sub>273-287</sub>
-tetramers, suggesting molecular mimicry. This public CDR3β uses TRBV4-2, a segment modulated by T1N-associated SNP rs1008599, suggesting causality. TCR-α/β CDR3 motifs of HCRT
<sub>54-66-NH2</sub>
and HCRT
<sub>86-97-NH2</sub>
tetramers were extensively shared: notably public CDR3α, TRAV2-CAVETDSWGKLQF-TRAJ24, that uses TRAJ24, a chain modulated by T1N-associated SNPs rs1154155 and rs1483979. TCR-α/β CDR3 sequences found in pHA
<sub>273-287</sub>
, NP
<sub>17-31</sub>
, and HCRT
<sub>NH2</sub>
tetramer-positive CD4
<sup>+</sup>
cells were also retrieved in single INF-γ-secreting CD4
<sup>+</sup>
sorted cells stimulated with Pandemrix, independently confirming these results. Our results provide evidence for autoimmunity and molecular mimicry with flu antigens modulated by genetic components in the pathophysiology of T1N.</AbstractText>
<CopyrightInformation>Copyright © 2018 the Author(s). Published by PNAS.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Luo</LastName>
<ForeName>Guo</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ambati</LastName>
<ForeName>Aditya</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lin</LastName>
<ForeName>Ling</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bonvalet</LastName>
<ForeName>Mélodie</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Partinen</LastName>
<ForeName>Markku</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Helsinki Sleep Clinic, Vitalmed Research Centre, 00380 Helsinki, Finland.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Clinical Neurosciences, University of Helsinki, 00100 Helsinki, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ji</LastName>
<ForeName>Xuhuai</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Immune Monitoring Center, Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Palo Alto, CA 94305.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maecker</LastName>
<ForeName>Holden Terry</ForeName>
<Initials>HT</Initials>
<AffiliationInfo>
<Affiliation>Immune Monitoring Center, Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Palo Alto, CA 94305.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mignot</LastName>
<ForeName>Emmanuel Jean-Marie</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo>
<Affiliation>Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, CA 94304; mignot@stanford.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HHSN272201300006C</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P50 NS023724</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>S10 OD020141</GrantID>
<Acronym>OD</Acronym>
<Agency>NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>12</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
<NlmUniqueID>7505876</NlmUniqueID>
<ISSNLinking>0027-8424</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000939">Epitopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000596229">HCRT protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D059866">HLA-DQ beta-Chains</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C069051">HLA-DQB1 antigen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006388">Hemagglutinins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000068797">Orexins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011948">Receptors, Antigen, T-Cell</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C563534">Narcolepsy 1</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001324" MajorTopicYN="N">Autoantigens</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D059866" MajorTopicYN="N">HLA-DQ beta-Chains</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006388" MajorTopicYN="N">Hemagglutinins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018716" MajorTopicYN="N">Molecular Mimicry</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009290" MajorTopicYN="N">Narcolepsy</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000068797" MajorTopicYN="N">Orexins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011948" MajorTopicYN="N">Receptors, Antigen, T-Cell</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">DQ0602</Keyword>
<Keyword MajorTopicYN="Y">TCR</Keyword>
<Keyword MajorTopicYN="Y">autoimmunity</Keyword>
<Keyword MajorTopicYN="Y">narcolepsy</Keyword>
<Keyword MajorTopicYN="Y">tetramer</Keyword>
</KeywordList>
<CoiStatement>Conflict of interest statement: E.M. occasionally consults and has received contracts from Jazz Pharmaceuticals, is and has been a Principal Investigator on clinical trials using sodium oxybate and Solriamfetol, Jazz Pharmaceutical products, for the treatment of T1N; none of these have any scientific relationships to the study.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>12</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>3</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>12</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">30541895</ArticleId>
<ArticleId IdType="pii">1818150116</ArticleId>
<ArticleId IdType="doi">10.1073/pnas.1818150116</ArticleId>
<ArticleId IdType="pmc">PMC6310865</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Nature. 2018 Oct;562(7725):63-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30232458</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Proteome Res. 2008 Jan;7(1):386-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18052119</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Invest. 2018 Jun 1;128(6):2642-2650</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29757191</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Genet. 2013;9(2):e1003270</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23459209</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2000 Jan 1;355(9197):39-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10615891</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sleep. 2009 Dec;32(12):1548</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20041589</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Autoimmun. 2013 Jun;43:26-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23497937</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Paediatr Respir Rev. 2018 Jan;25:14-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28108192</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci Rep. 2015 Nov 05;5:16178</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26538451</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2000 Sep;6(9):991-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10973318</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Chem Biol. 2018 Oct;14(10):934-942</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30224695</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vaccine. 2012 Jan 17;30(4):745-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22138177</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2010 May 27;6(5):e1000918</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20523898</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sleep. 2014 Oct 01;37(10):1601-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25197808</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2014 Sep 29;9(9):e108489</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25264897</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Hum Mol Genet. 2015 Feb 1;24(3):891-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25256355</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Neuroimmunol. 2017 Aug 15;309:7-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28601291</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Invest. 2010 Mar;120(3):713-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20160349</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Neuron. 2000 Sep;27(3):469-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11055430</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sleep. 2017 Feb 01;40(2):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28364500</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Neurol. 2011 Sep;70(3):410-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21866560</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nucleic Acids Res. 2012 Jul;40(Web Server issue):W525-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22610854</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Intern Med. 2015 Oct;278(4):335-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26123389</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2017 Jul 6;547(7661):94-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28636589</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Genet. 2009 Jun;41(6):708-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19412176</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Immunol. 2005 May;6(5):490-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15821740</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Med Res. 2016 Jul;8(7):495-505</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27298657</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sleep. 2017 Mar 01;40(3):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28364420</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Commun. 2018 Jan 24;9(1):353</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29367624</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Autoimmun. 2014 May;50:99-106</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24485154</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):10956-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27621438</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2014 Dec 15;9(12):e114361</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25501681</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Genet. 2013 Oct;9(10):e1003880</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24204295</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Genet. 2016 Sep;48(9):995-1002</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27479906</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Immunol. 2018 May;18(5):325-339</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29292391</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Intern Med. 2015 Sep;278(3):264-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25683265</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell. 1998 Feb 20;92(4):573-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9491897</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sleep. 2009 Aug;32(8):979-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19725248</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Genes Dev. 2013 Mar 1;27(5):565-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23431030</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci Transl Med. 2015 Jul 1;7(294):294ra105</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26136476</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci Transl Med. 2014 Jul 30;6(247):247rt1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25080479</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2017 Dec 8;12(12):e0187305</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29220370</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Brain Behav Immun. 2015 Jul;47:44-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25452148</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Genet. 2011 Jan;43(1):66-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21170044</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sleep Med. 2014 Jun;15(6):607-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24767723</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Hum Genet. 2001 Mar;68(3):686-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11179016</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sleep. 2014 Jan 01;37(1):19-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24381371</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Tissue Antigens. 2012 Oct;80(4):328-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22862152</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sleep. 2006 May;29(5):633-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16774153</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Genet. 2010 Sep;42(9):786-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20711174</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Neurol. 2013 Apr;73(4):560</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23225098</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cancer Sci. 2008 Aug;99(8):1633-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18754877</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Curr Neurol Neurosci Rep. 2018 Jun 1;18(7):43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29855798</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Immunol. 2018 Jul;18(7):467-478</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29636542</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vaccine. 2018 Oct 1;36(41):6202-6211</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30122647</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci Transl Med. 2013 Dec 18;5(216):216ra176</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24353159</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Hum Genet. 2015 Jan 8;96(1):136-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25574827</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Neuroimmunol. 2015 Jun 15;283:58-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26004157</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000012 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000012 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:30541895
   |texte=   Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:30541895" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a H2N2V1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021